Jonas Brambeck
Board member
Pharmaceuticals
Oncopeptides
Sweden
Biography
Jonas Brambeck was appointed to the board of Oncopeptides in 2008. In addition to being a board member of Oncopeptides, Jonas is an Investment Manager at Industrifonden, a leading Nordic venture capital fund, and a member of the Board of Directors of the life sciences companies Oxthera AB, Cardoz AB and Nuevolution AS. He has previously held positions at a number of life sciences businesses including AstraZeneca, Bruker Instruments and Nobel. Jonas holds a PhD in organic chemistry from The Royal Institute of Technology in Stockholm.
Research Interest
life sciences businesses
